Skip to content
drillr.ai
Sign up

EYPT

EyePoint Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.58
+0.33%
Ask drillr
1
Insider buys (3m)
2
Insider sells (3m)
-$20.9K
Net value (3m)
-60.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Zaderej Karen L. · directorPurchase10,600$4.93
Jul 14, 2026Duker Jay S. · director, officer: President and CEOF-InKind8,059$15
Jul 14, 2026Duker Jay S. · director, officer: President and CEOM-Exempt16,667$0.00
Jul 2, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt2,438$8.26
Jul 2, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale2,438$15
Jul 2, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale2,437$15
Jul 2, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt2,437$8.26
May 27, 2026Elston George · officer: Chief Financial OfficerF-InKind3,627$13
May 27, 2026Elston George · officer: Chief Financial OfficerM-Exempt7,500$0.00
Apr 20, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt2,437$8.26
Apr 20, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale2,437$15
Mar 16, 2026Duker Jay S. · director, officer: President and CEOPurchase1,500$13
Mar 5, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale2,438$18
Mar 5, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt2,438$8.26
Feb 18, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale2,437$15
Feb 18, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt2,437$8.26
Jan 7, 2026Duker Jay S. · director, officer: President and CEOM-Exempt20,793$0.00
Jan 7, 2026Elston George · officer: Chief Financial OfficerM-Exempt15,285$0.00
Jan 7, 2026Ribeiro Ramiro · officer: Chief Medical OfficerM-Exempt29,250$8.26
Jan 7, 2026Elston George · officer: Chief Financial OfficerF-InKind4,487$17
Jan 7, 2026Lurker Nancy · directorM-Exempt75,133$0.00
Jan 7, 2026Duker Jay S. · director, officer: President and CEOF-InKind10,054$17
Jan 7, 2026Ribeiro Ramiro · officer: Chief Medical OfficerSale42,544$17
Jan 6, 2026Landis John B. · directorA-Award40,000$17
Jan 6, 2026Lurker Nancy · directorM-Exempt12,666$0.00
Jan 6, 2026Duker Jay S. · director, officer: President and CEOA-Award331,000$17
Jan 6, 2026Sanders Reginald J. · directorA-Award40,000$17
Jan 6, 2026Lurker Nancy · directorA-Award40,000$17
Jan 6, 2026Duker Jay S. · director, officer: President and CEOA-Award165,000$0.00
Jan 6, 2026Duty Stuart · directorA-Award40,000$17
Institutional positioning

13F filings over the trailing two quarters

New 75Increased 141Reduced 106Sold out 23
FilerActionSharesFiled
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged8,296,375Aug 14, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCIncreased8,296,375May 15, 2026
CORMORANT ASSET MANAGEMENT, LPUnchanged8,265,000May 15, 2026
BlackRock, Inc.Increased7,463,197Aug 7, 2026
BLACKROCK, INC.Increased7,177,337May 13, 2026
Cormorant Asset Management, LPReduced7,000,000Aug 14, 2026
FEDERATED HERMES, INC.Increased5,681,052Aug 12, 2026
FEDERATED HERMES, INC.Reduced5,669,589May 11, 2026
FRANKLIN RESOURCES INCIncreased5,048,598May 13, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased4,827,792Aug 14, 2026
FRANKLIN RESOURCES INCReduced4,807,078Aug 13, 2026
Commodore Capital LPIncreased4,600,000Aug 14, 2026
Jupiter Topco LLCNew Position3,770,381Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,630,252Aug 13, 2026
JANUS HENDERSON GROUP PLCIncreased3,601,168May 18, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026